Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Scynexis Inc (SCYX)

Scynexis Inc (SCYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Scynexis: Q1 Earnings Snapshot AP - Wed May 8, 3:51PM CDT

Scynexis: Q1 Earnings Snapshot

SCYX : 1.8700 (-3.61%)
Scynexis: Q3 Earnings Snapshot AP - Mon Nov 13, 2023

Scynexis: Q3 Earnings Snapshot

SCYX : 1.8700 (-3.61%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SCYNEXIS, Inc. - SCYX PR Newswire - Tue Oct 17, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of SCYNEXIS, Inc. ("SCYNEXIS" or the "Company") (NASDAQ: SCYX). Such investors are...

SCYX : 1.8700 (-3.61%)
The Law Offices of Frank R. Cruz Announces Investigation of SCYNEXIS, Inc. (SCYX) on Behalf of Investors PR Newswire - Fri Oct 6, 2023

/PRNewswire/ -- The Law Offices of Frank R. Cruz announces an investigation of SCYNEXIS, Inc. ("SCYNEXIS" or the "Company") (NASDAQ: SCYX) on behalf of...

SCYX : 1.8700 (-3.61%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SCYNEXIS, Inc. - SCYX PR Newswire - Fri Sep 29, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of SCYNEXIS, Inc. ("SCYNEXIS" or the "Company") (NASDAQ: SCYX). Such investors are...

SCYX : 1.8700 (-3.61%)
Scynexis: Q2 Earnings Snapshot AP - Mon Aug 14, 2023

Scynexis: Q2 Earnings Snapshot

SCYX : 1.8700 (-3.61%)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating SCYNEXIS, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors PR Newswire - Tue Jun 20, 2023

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

SCYX : 1.8700 (-3.61%)
Scynexis: Q1 Earnings Snapshot AP - Thu May 11, 2023

Scynexis: Q1 Earnings Snapshot

SCYX : 1.8700 (-3.61%)
SCYNEXIS (NASDAQ: SCYX) Enters Into Exclusive Agreement with GSK (NYSE: GSK) to Continue Commercializing Brexafemme to Treat Fungal Infections Spotlight Growth - Thu Mar 30, 2023

SCYNEXIS, Inc. (NASDAQ: SCYX) operates as a biotechnology company, which is focused on the research and development of novel solutions

SCYX : 1.8700 (-3.61%)
GSK : 38.84 (+0.99%)
Scynexis: Q3 Earnings Snapshot AP - Wed Nov 9, 2022

Scynexis: Q3 Earnings Snapshot

SCYX : 1.8700 (-3.61%)

Barchart Exclusives

3 Standout Stocks to Buy for Q3 2024 Barchart - 58 minutes ago
As we enter the third quarter of 2024, here are three promising stocks investors could consider buying. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot